The airway epithelium is central to the pathogenesis of asthma

Allergology International

Volumn 57, Issue 1, 2008, Pages 1-10

  Holgate, Stephen T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Airway remodeling; Asthma; Disease susceptible genes; Epithelial mesenchymal trophic unit (EMTU); Thymic stromal lymphopoietin (TSLP)

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 11; INTERLEUKIN 13; NEUROTROPHIN; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

AIRWAY OBSTRUCTION; ASTHMA; AUTOCRINE EFFECT; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; CILIATED EPITHELIUM; CLINICAL FEATURE; EOSINOPHIL; GOBLET CELL; GRANULOCYTE FUNCTION; HUMAN; INFLAMMATORY INFILTRATE; LUNG FIBROSIS; LUNG LAVAGE; MUCOUS CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RESPIRATORY EPITHELIUM; REVIEW;

EID: 40949121542     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.R-07-154     Document Type: Review

References (91)

1. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N. Engl. J. Med. 2006;355:2226-2235.
2. Pearce N, Pekkanen J, Beasley R. 1999. How much asthma is really attributable to atopy? Thorax 2006;54:268-272.
3. Hammad H, Lambrecht BN. Recent progress in the biology of airway dendritic cells and implications for understanding the regulation of asthmatic inflammation. J. Allergy Clin. Immunol. 2006;118:331-336.
4. Colognato R, Slupsky JR, Jendrach M, Burysek L, Syrovets T, Simmet T. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells. Blood 2003;102:2645-2652.
5. Holgate ST. The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol. 2007;28:248-251.
6. Allakhverdi Z, Comeau MR, Jessup HK et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J. Exp. Med. 2007;204:253-258.
7. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP. Activation of airway epithelial cells by toll-like receptor agonists. Am. J Respir. Cell Mol. Biol. 2004;31:358-364.
8. Holgate ST. Rhinoviruses in the pathogenesis of asthma: the bronchial epithelium as a major disease target. J. Allergy Clin. Immunol. 2006;118:587-590.
9. Kato A, Favoreto S Jr, Avila PC, Schleimer RP. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J. Immunol. 2007;179:1080-1087.
10. Barbato A, Turato G, Baraldo S et al. Epithelial damage and angiogenesis in the airways of children with asthma. Am. J. Respir. Crit. Care Med. 2006;174:975-981.
11. Fedorov LA, Wilson SJ, Davies DE, Holgate ST. Epithelial stress and structural remodelling in childhood asthma. Thorax 2005;60:389- 394.
12. Bousquet J, Yssel H, Vignola AM. Is allergic asthma associated with delayed fetal maturation or the persistence of conserved fetal genes? Allergy 2000;55:1194-1197.
13. Plopper CG, Smiley-Jewell SM, Miller LA et al. Asthma/allergic airways disease: does postnatal exposure to environmental toxicants promote airway pathobiology? Toxicol. Pathol. 2007;35:97-110.
14. Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST. Airway remodeling in asthma: new insights. J. Allergy Clin. Immunol. 2003;111:215-225.
15. Roche WR, Montefort S, Baker J, Holgate ST. Cell adhesion molecules and the bronchial epithelium. Am. Rev. Respir. Dis. 1993;148:S79-S82.
16. Knight D. Increased permeability of asthmatic epithelial cells to pollutants. Does this mean that they are intrinsically abnormal? Clin. Exp. Allergy 2002;32:1263-1265.
17. Hogg JC. Pathology of asthma. J. Allergy Clin. Immunol. 1993;92:1-5.
18. Shahana S, Jaunmuktane Z, Asplund MS, Roomans GM. Ultrastructural investigation of epithelial damage in asthmatic and non-asthmatic nasal polyps. Respir. Med. 2006;100:2018-2028.
19. Shebani E, Shahana S, Janson C, Roomans GM. Attachment of columnar airway epithelial cells in asthma. Tissue Cell 2005;37:145-152.
20. Bertorelli G, Bocchino V, Zhuo X et al. Heat shock protein 70 upregulation is related to HLA-DR expression in bronchial asthma. Effects of inhaled glucocorticoids. Clin. Exp. Allergy 1998;8:551-560.
21. Bucchieri F, Puddicombe SM, Lordan JL et al. Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am. J. Respir. Cell Mol. Biol. 2002;27:179-185.
22. Comhair SA, Bhathena PR, Farver C, Thunnissen FB, Erzurum SC. Extracellular glutathione peroxidase induction in asthmatic lungs: evidence for redox regulation of expression in human airway epithelial cells. FASEB J. 2001;15:70-78.
23. Ercan H, Birben E, Dizdar EA et al. Oxidative stress and genetic and epidemiologic determinants of oxidant injury in childhood asthma. J. Allergy Clin. Immunol. 2006;118:1097-1104.
24. Mak JC, Ho SP, Leung HC et al. Relationship between glutathione S-transferase gene polymorphisms and enzyme activity in Hong Kong Chinese asthmatics. Clin. Exp. Allergy 2007;37:1150-1157.
25. Cohen L, Tarsi EX J, Ramkumar T et al. Epithelial cell proliferation contributes to airway remodeling in severe asthma. Am. J. Respir. Crit. Care Med. 2007;176:138-145.
26. Truong-Tran AQ, Ruffin RE, Foster PS. Altered zinc homeostasis and caspase-3 activity in murine allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 2002;27:286-296.
27. Polosa R, Puddicombe SM, Krishna MT et al. Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects. J. Allergy Clin. Immunol. 2002;109:75-81.
28. Hamilton LM, Puddicombe SM, Dearman RJ et al. Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium. Eur. Respir. J. 2005;25:978-985.
29. Hamilton LM, Torres-Lozano C, Puddicombe SM et al. The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clin. Exp. Allergy 2003;33:233-240.
30. Merendino AM, Bucchieri F, Gagliardo R et al. CD40 ligation protects bronchial epithelium against oxidant-induced caspase-independent cell death. Am. J. Respir. Cell Mol. Biol. 2006;35:155-164.
31. Ritter M, Mennerich D, Weith A, Seither P. Characterization of Toll-like receptors in primary lung epithelial cells: strong impact of the TLR3 ligand poly (I: C) on the regulation of Toll-like receptors, adaptor proteins and inflammatory response. J. Inflamm. (Lond) 2005;2:16.
32. Knight D. Increased permeability of asthmatic epithelial cells to pollutants. Does this mean that they are intrinsically abnormal? Clin. Exp. Allergy 2002;32:1263-1265.
33. Knight DA, Holgate ST. The airway epithelium: structural and functional properties in health and disease. Respirology 2003;8:432-446.
34. lowite JS, Bennett WD, Sheetz MS, Groth ML, Nierman DM. Permeability of the bronchial mucosa to 99mTc-DTPA in asthma. Am. Rev. Respir. Dis. 1989;139:1139-1143.
35. Wan H, Winton HL, Soeller C et al. Quantitative structural and biochemical analyses of tight junction dynamics following exposure of epithelial cells to house dust mite allergen Der p 1. Clin. Exp. Allergy 2000;30:685-698.
36. Puddicombe SM, Torres-Lozano C, Richter A et al. Increased expression of p21 (waf) cyclin-dependent kinase inhibitor in asthmatic bronchial epithelium. Am. J. Respir. Cell Mol. Biol. 2003;28:61-68.
37. Chu EK, Cheng J, Foley JS et al. Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 2006;35:628-638.
38. Kaplan AP, Joseph K, Silverberg M. Pathways for bradykinin formation and inflammatory disease. J. Allergy Clin. Immunol. 2002;109:195-209.
39. Kicic A, Sutanto EN, Stevens PT, Knight DA, Stick SM. Intrinsic biochemical and functional differences in bronchial epithelial cells of children with asthma. Am. J. Respir. Crit Care Med. 2006;174:1110-1118.
40. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989;1:520-524.
41. Karjalainen EM, Lindqvist A, Laitinen LA et al. Airway inflammation and basement membrane tenascin in newly diagnosed atopic and nonatopic asthma. Respir. Med. 2003;97:1045-1051.
42. Payne DN, Rogers AV, Adelroth E et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am. J. Respir. Crit. Care Med. 2003;167:78-82.
43. Pohunek P, Warner JO, Turzikova J, Kudrmann J, Roche WR. Markers of eosinophilic inflammation and tissue remodelling in children before clinically diagnosed bronchial asthma. Pediatr. Allergy Immunol. 2005;16:43-51.
44. Saglani S, Malmstrom K, Pelkonen AS et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am. J. Respir. Crit. Care Med. 2005;171:722-727.
45. Ward C, De SA, Fisher AJ, Pritchard G, Forrest I, Corris P. A descriptive study of small airway reticular basement membrane thickening in clinically stable lung transplant recipients. J. Heart Lung Transplant 2005;24:533-537.
46. Law L, Zheng L, Orsida B et al. Early changes in basement membrane thickness in airway walls post-lung transplantation. J. Heart Lung Transplant 2005;24:1571-1576.
47. Saglani S, Molyneux C, Gong H et al. Ultrastructure of the reticular basement membrane in asthmatic adults, children and infants. Eur. Respir. J. 2006;28:505-512.
48. Leung SY, Niimi A, Noble A et al. Effect of transforming growth factor-beta receptor I kinase inhibitor 2,4-disubstituted pteridine (SD-208) in chronic allergic airway inflammation and remodeling. J. Pharmacol. Exp. Ther. 2006;319:586-594.
49. Locke NR, Royce SG, Wainewright JS, Samuel CS, Tang ML. Comparison of airway remodeling in acute, subacute, and chronic models of allergic airways disease. Am. J. Respir. Cell Mol. Biol. 2007;36:625-632.
50. Zhang S, Smartt H, Holgate ST, Roche WR. Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro co-culture model of airway remodeling in asthma. Lab. Invest. 1999;79:395-405.
51. Choe MM, Sporn PH, Swartz MA. An in vitro airway wall model of remodeling. Am. J. Physiol. Lung Cell Mol. Physiol 2003;285:L427- L433.
52. Phipps S, Benyahia F, Ou TT, Barkans J, Robinson DS, Kay AB. Acute allergen-induced airway remodeling in atopic asthma. Am. J. Respir. Cell Mol. Biol. 2004;31:626-632.
53. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am. J. Respir. Crit. Care Med. 2003;167:199-204.
54. Liu LY, Sedgwick JB, Bates ME et al. Decreased expression of membrane IL-5 receptor alpha on human eosinophils: II. IL-5 down-modulates its receptor via a proteinase-mediated process. J. Immunol. 2002;169:6459-6466.
55. Park CS, Choi YS, Ki SY et al. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways. Eur. Respir. J. 1998;12:872-878.
56. Leckie MJ, ten Brinke A, Khan J et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2149-2153.
57. Kay AB, Phipps S, Robinson DS. A role for eosinophils in airway remodelling in asthma. Trends Immunol. 2004;25:477-482.
58. Phipps S, Ying S, Wangoo A, Ong YE, Levi-Schaffer F, Kay AB. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J. Immunol. 2002;169:4604- 4612.
59. Kariyawasam HH, Aizen M, Barkans J, Robinson DS, Kay AB. Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. Am. J. Respir. Crit. Care Med. 2007;175:896- 904.
60. Brightling CE, Symon FA, Birring SS, Bradding P, Wardlaw AJ, Pavord ID. Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 2003;58:528-532.
61. Lee YM, Park JS, Hwang JH et al. High-resolution CT findings in patients with near-fatal asthma: comparison of patients with mild-to-severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment. Chest 2004;126:1840-1848.
62. Vignola AM, Paganin F, Capieu L et al. Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur. Respir. J. 2004;24:910-917.
63. Pepe C, Foley S, Shannon J et al. Differences in airway remodeling between subjects with severe and moderate asthma. J. Allergy Clin. Immunol. 2005;116:544-549.
64. Pini L, Hamid Q, Shannon J et al. Differences in proteoglycan deposition in the airways of moderate and severe asthmatics. Eur. Respir. J. 2007;29:71-77.
65. Park JW, Hong YK, Kim CW, Kim DK, Choe KO, Hong CS. High-resolution computed tomography in patients with bronchial asthma: correlation with clinical features, pulmonary functions and bronchial hyperresponsiveness. J. Investig. Allergol. Clin. Immunol. 1997;7:186-192.
66. Park SW, Park JS, Lee YM et al. Differences in radiological/HRCT findings in eosinophilic bronchitis and asthma: implication for bronchial responsiveness. Thorax 2006;61:41-47.
67. Shaw TJ, Wakely SL, Peebles CR et al. Endobronchial ultrasound to assess airway wall thickening: validation in vitro and in vivo. Eur. Respir. J. 2004;23:813-817.
68. Ayres JG, Jyothish D, Ninan T. Brittle asthma. Paediatr. Respir. Rev. 2004;5:40-44.
69. Willis BC, Liebler JM, Luby-Phelps K et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta 1: potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 2005;166:1321-1332.
70. Nihlberg K, Larsen K, Hultgardh-Nilsson A, Malmstrom A, Bjermer L, Westergren-Thorsson G. Tissue fibrocytes in patients with mild asthma: a possible link to thickness of reticular basement membrane? Respir. Res. 2006;7:50.
71. Kim KK, Kugler MC, Wolters PJ et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl. Acad. Sci. U.S.A. 2006;103:13180-13185.
72. Wu Z, Yang L, Cai L et al. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse. Respir. Res. 2007;8:1.
73. Ward C, Forrest IA, Murphy DM et al. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax 2005;60:865- 871.
74. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 2003;171:380-389.
75. Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab. Invest. 2007;87:858-870.
76. Rousseau K, Byrne C, Griesinger G et al. Allelic Association and Recombination Hotspots in the Mucin Gene (MUC) Complex on Chromosome 11p15.5. Ann. Hum. Genet. 2007;71:561-569.
77. Ordonez CL, Khashayar R, Wong HH et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am. J. Respir. Crit. Care Med. 2001;163:517-523.
78. Shimura S, Andoh Y, Haraguchi M, Shirato K. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur. Respir. J. 1996;9:1395-1401.
79. Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol. Rev. 2006;86:245-278.
80. Burgel PR, Montani D, Danel C, Dusser DJ, Nadel JA. A morphometric study of mucins and small airway plugging in cystic fibrosis. Thorax 2007;62:153-161.
81. Deshmukh HS, Case LM, Wesselkamper SC et al. Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation. Am. J. Respir. Crit. Care Med. 2005;171:305-314.
82. Lordan JL, Bucchieri F, Richter A et al. Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells. J. Immunol. 2002;169:407-414.
83. Shao MX, Nadel JA. Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 2005;102:767-772.
84. Elias JA, Kang MJ, Crouthers K, Homer R, Lee CG. State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice. Proc. Am. Thorac. Soc. 2006;3:494-498.
85. Long AJ, Sypek JP, Askew R et al. Gob-5 contributes to goblet cell hyperplasia and modulates pulmonary tissue inflammation. Am. J. Respir. Cell Mol. Biol. 2006;35:357-365.
86. Guilbert TW, Morgan WJ, Zeiger RS et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N. Engl. J. Med. 2006;354:1985-1997.
87. Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. Lancet 2006;368:754-762.
88. No Authors listed. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N. Engl. J. Med. 2000;343:1054-1063.
89. Pauwels RA, Pedersen S, Busse WW et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003;361:1071-1076.
90. Holloway J, Holgate ST. Identification and function of a novel candidate gene for asthma. Allergol. Int. 2005;54:25-30.
91. Holloway JW, Koppelman GH. Identifying novel genes contributing to asthma pathogenesis. Curr. Opin. Allergy Clin. Immunol. 2007;7:69-74.